Physician profile
Scott Yang
NPI 1093959330
$10,828.53
in general payments reported to CMS, 2019-2025
11 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,922 · 2020: $631 · 2021: $4,733 · 2022: $321 · 2023: $134 · 2024: $1,351 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,511 · Food and Beverage: $632 · Travel and Lodging: $78.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,511.25 |
| Food and Beverage | $632.05 |
| Travel and Lodging | $78.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $3,600.00 | 2021 | |
| Smith+Nephew, INC. | $2,538.85 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,742.17 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,597.91 | 2024-2025 | Skyline |
| Medtronic, INC. | $387.62 | 2021-2023 | O-Arm, Mazor X System, Cd Horizon Spinal System |
| Orthopediatrics Corp. | $320.82 | 2024-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $181.97 | 2022 | |
| Nuvasive, INC. | $164.50 | 2019 | |
| Medtronic USA, INC. | $125.91 | 2019 | |
| Depuy Synthes Sales INC. | $89.31 | 2024-2025 | Expedium Verse, Trialtis |
| Stryker Corporation | $79.47 | 2024 | Everest Spinal System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.